Codiak BioSciences, Inc.
CDAKDelisted May 2, 2023- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001659352
Codiak BioSciences, Inc. was delisted on May 2, 2023; its insiders filed their last Form 4 on Mar 30, 2023; 27 institutions reported holding it in 13F filings for Q1 2023, worth $1.44M in total; no superinvestor held it.
Q4 2021 vs. Q3 2021
How the institutions holding Codiak BioSciences, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Of which not filed for Q4 2021 | Q4 2021 | Change |
|---|---|---|---|---|
| Holders | 56 | 1 | 51 | −4 |
| Shares | 13.7M | 20.3K | 13.4M | −217.3K (−1.6%) |
| Value | $223.6M | $332.0K | $145.4M | −$77.8M (−34.9%) |
1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (5)
Institutions that held Codiak BioSciences, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| HighTower Advisors, LLC | 21,328 | $237.0K | 0.00% |
| Susquehanna International Group, LLP | 14,292 | $159.0K | 0.00% |
| Allspring Global Investments Holdings, LLC | 4,258 | $47.0K | 0.00% |
| Simplex Trading, LLC | 351 | $3.00K | 0.00% |
| Advisor Group Holdings, Inc. | 19 | $0 | 0.00% |
Sold out (9)
Institutions that held Codiak BioSciences, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse) | 142,978 | $2.33M |
| Jacobs Levy Equity Management, Inc | 22,129 | $361.0K |
| Boothbay Fund Management, LLC | 12,082 | $197.0K |
| Virtus ETF Advisers LLC | 8,316 | $136.0K |
| MetLife Investment Management | 6,809 | $111.2K |
| Metropolitan Life Insurance Co | 5,152 | $84.1K |
| TSFG, LLC | 1,000 | $16.0K |
| Harbour Investments, Inc. | 65 | $1.00K |
| Parallel Advisors, LLC | 67 | $1.00K |
Not filed for Q4 2021 yet (1)
Institutions that held Codiak BioSciences, Inc. at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Freed Investment Group | 20,328 | $332.0K |